This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Antiretroviral chemotherapy in HIV infection

Authoring team

There are six main categories of antiretroviral drugs used in HIV infection:

  • nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs):
    • AZT (zidovudine)
    • ddI (didanosine)
    • ddC (zalcitabine)
    • d4T (stavudine)
    • 3TC (lamivudine)
    • abacavir
  • non-nucleoside analogue inhibitors of reverse transcriptase (NNRTIs):
    • etravirine
    • delavirdine
    • nevirapine
    • efavirenz
  • integrase inhibitors
    • raltegravir (RAL)
    • elvitegravir (EVG)
  • protease inhibitors (PIs):
    • amprenavir (APV, Agenerase)
    • atazanavir (ATZ, Reyataz)
    • saquinavir
    • ritonavir
    • indinavir
    • nelfinavir
    • lopinavir
  • fusion inhibitors – prevents fusion of viral membrane with the cell membrane
    • enfuvirtide T-20 (1)
  • coreceptor antagonists

Some serious or unusual side effects of antiretroviral therapy are:

  • NRTI’s – hypersensitivity, lactic acidosis and hepatomagaly, bone marrow suppression, pancreatitis, peripheral neuropathy, lipoatrophy
  • NNRTI’s – hypersensitivity hepatic toxicity, psychiatric problems
  • PI’s – hepatic toxicity, hyperlipdaemia, lipodystrophy, type 2 diabetes, ureteric colic, nephrolithiasis (1)

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.